FDA Clearance Tracker · K262913
Protégé EverFlex Self-expanding Peripheral Stent System
Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Sep 17, 2026
Substantially Equivalent
Time to decision
29 days
Received Aug 19, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K262913
- Device name
- Protégé EverFlex Self-expanding Peripheral Stent System
- Applicant
- Medtronic, Inc.
- Applicant location
- Plymouth, MN
- Received
- Aug 19, 2026
- Decided
- Sep 17, 2026
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.5010
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code FGE. The earliest in FDA's data is K821817, decided Aug 10, 1982.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K262913
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
K262735 · Decided Aug 28, 2026 · 28 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
K262005 · Decided Aug 21, 2026 · 67 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.